Successful fertility-preserving management of a viable cesarean scar ectopic pregnancy: a case report.
This case illustrates that a multidisciplinary approach to managing viable cesarean scar ectopic pregnancy can effectively reduce hemorrhagic risk while preserving fertility.
Where it sits
this study against the rest of the hcg (human chorionic gonadotropin) corpusSummary and findings
This case report discusses the management of a viable cesarean scar ectopic pregnancy in a 27-year-old woman who had persistent fetal cardiac activity despite treatment with methotrexate. A multidisciplinary approach involving prophylactic bilateral uterine artery embolization and laparoscopic suction curettage was utilized. The patient had an estimated blood loss of 20 mL and normalized β-hCG levels at follow-up.
Abstract
Cesarean scar ectopic pregnancy (CSEP) is an increasingly recognized complication of prior cesarean delivery, associated with uterine rupture, hemorrhage, and hysterectomy. This report presents a case of viable cesarean scar ectopic pregnancy with persistent fetal cardiac activity despite systemic methotrexate, successfully managed with a multidisciplinary, fertility-preserving approach. A 27-year-old woman (G7P5) with two prior cesarean deliveries presented at 5 weeks of gestation with vaginal spotting and pelvic pain. Initial transvaginal ultrasound showed a viable intrauterine pregnancy. She developed heavy bleeding, and repeat ultrasound revealed a gestational sac implanted in the anterior lower uterine segment at the prior cesarean scar with persistent fetal cardiac activity. A one-week, four-dose course of intramuscular methotrexate was initiated; however, gestational tissue showed minimal change and β-hCG levels remained elevated. Given her desire for future fertility and the hemorrhagic risk of surgical evacuation alone, a multidisciplinary approach involving maternal-fetal medicine, interventional radiology, and gynecologic surgery was pursued. Prophylactic bilateral uterine artery embolization followed by laparoscopy and ultrasound-guided suction curettage was successfully performed with an estimated blood loss of 20 mL. At follow-up, the patient remained clinically well with normalized β-hCG levels. As cesarean delivery rates rise, cesarean scar ectopic pregnancy and its complications are expected to increase. Management should be individualized based on fetal viability, myometrial invasion, and reproductive goals. While conservative treatment may be appropriate in select cases, viable cesarean scar ectopic pregnancy with persistent cardiac activity requires multimodal management. This case demonstrates that prophylactic uterine artery embolization followed by minimally invasive evacuation can reduce hemorrhagic risk while preserving fertility.
Background
Cesarean scar ectopic pregnancy (CSEP) is a complication that can arise following cesarean deliveries, with risks including uterine rupture and hemorrhage. Previous management strategies often involve surgical intervention, but this report highlights a fertility-preserving approach. Understanding effective management options for CSEP is critical as cesarean delivery rates continue to rise.
Methods
This case report details the management of a single patient, a 27-year-old woman (G7P5) presenting at 5 weeks of gestation. Initial treatment involved a one-week, four-dose course of intramuscular methotrexate, followed by a multidisciplinary intervention including bilateral uterine artery embolization and laparoscopic suction curettage. The primary outcome was the reduction of hemorrhagic risk while preserving fertility.
Results
The estimated blood loss during the procedure was 20 mL. Following the intervention, the patient had normalized β-hCG levels at follow-up.
Interpretation
This case adds to the limited literature on managing viable CSEP, suggesting that a multidisciplinary approach can be effective in preserving fertility while minimizing complications. The small estimated blood loss indicates a potentially favorable outcome, but the clinical significance of this case is limited by its single-patient design. Further studies are needed to validate these findings across larger populations.
Key findings
- Estimated blood loss of 20 mL during the procedure.
- Patient remained clinically well at follow-up with normalized β-hCG levels.
Limitations
- Single case report with n=1.
- No control group for comparison.
- Not reported in abstract.